¼¼°èÀÇ ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¿¹Ãø(2024-2032³â)
Global Biopharmaceutical Excipients Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1542632
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 131 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 31¾ï 2,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â ¾à 53¾ï 2,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024-2032³âÀÇ CAGRÀº 6.12%·Î ¿¹»óµË´Ï´Ù.

¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦´Â ¹é½Å, ´ÜŬ·ÐÇ×ü, À¯ÀüÀÚ Ä¡·á µîÀÇ ¹ÙÀÌ¿À ÀǾàǰÀ» Á¦ÇüÈ­ÇÏ´Â ºÒȰ¼º ¹°ÁúÀÔ´Ï´Ù. À¯È¿¼ººÐÀÇ ¾ÈÁ¤È­, ¿ëÇØ¼ºÀÇ Çâ»ó, ¾à¹°Àü´ÞÀÇ °³¼± µî, ´Ù¾çÇÑ ±â´ÉÀ» ¿Ï¼öÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ã·°¡Á¦´Â ¾ÈÁ¤Á¦, º¸Á¸Á¦, ¿ëÇØÁ¦ µîÀÇ ¹°ÁúÀ» Æ÷ÇÔÇϸç, ¹ÙÀÌ¿À ÀǾàǰÀÇ È¿´É, ¾ÈÀü¼º ¹× ǰÁúÀ» È®º¸Çϴµ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±âÁ¸ÀÇ ÀǾàǰ¿¡ »ç¿ëµÇ´Â ÷°¡Á¦¿Í ´Þ¸® ÀǾàǰ Ȱ¼º ¼ººÐ(API)ÀÇ »ý¹°ÇÐÀû Ȱ¼ºÀ» ÀúÇØÇÏÁö ¾Êµµ·Ï ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç ¹× ÀûÇÕ¼º ±âÁØÀ» ÃæÁ·ÇØ¾ß ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

»ý¹° Á¦Á¦¿Í ÷´Ü Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰ ºÎ¹®ÀÌ È®´ëµÊ¿¡ µû¶ó »ý¹° Á¦Á¦ÀÇ ¾ÈÁ¤¼º, Àü´Þ ¹× È¿´ÉÀ» ³ôÀ̱âÀ§ÇÑ Æ¯¼ö ÷°¡Á¦ÀÇ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÷°¡Á¦´Â ´ÜÀÏŬ·Ð Ç×ü ¹× À¯ÀüÀÚ Ä¡·á¿Í °°Àº º¹ÀâÇÑ »ý¹°ÇÐÀû Á¦Á¦ÀÇ Á¦ÇüÈ­¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϸç, Á¦Ç°ÀÇ Ç°Áú°ú ¼º´ÉÀ» À¯ÁöÇϱâ À§Çؼ­´Â °¢°¢¿¡ ¸Â´Â ÷°¡Á¦ ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÷°¡Á¦ °³¹ßÀÇ ±â¼ú Áøº¸´Â ½ÃÀå¿¡ Å« ±âȸ¸¦ °¡Á®¿Ô½À´Ï´Ù. »õ·Î¿î ¾ÈÁ¤Á¦ ¹× °í±Þ Àü´Þ ½Ã½ºÅÛ°ú °°Àº ÷°¡Á¦ ±â¼úÀÇ Çõ½ÅÀº ¹ÙÀÌ¿À ÀǾàǰÀÇ Á¦ÇüÈ­ ¹× Á¦Á¶¸¦ °³¼±Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áøº¸´Â º¸´Ù È¿°úÀûÀÌ°í ¾ÈÀüÇÑ Ä¡·áÀÇ °³¹ßÀ» °¡´ÉÇÏ°Ô Çϰí ÷´Ü ÷°¡Á¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½É Áõ°¡´Â ¶ÇÇÑ ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °³ÀÎÈ­ Ä¡·á¿¡´Â Á¾Á¾ Á¦ÇüÀÇ µ¶Æ¯ÇÑ °úÁ¦¸¦ ÇØ°áÇÏ°í ¾à¹° Àü´ÞÀ» ÃÖÀûÈ­Çϱâ À§ÇØ Æ¯¼ö ÷°¡Á¦°¡ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ Ãß¼¼´Â ¼ºÀåÇÏ´Â °³ÀÎÈ­µÈ ÀÇ·á ºÎ¹®À» Áö¿øÇϱâ À§ÇØ ¸ÂÃãÇü ÷°¡Á¦ ¼Ö·ç¼ÇÀÇ °³¹ßÀ» ÃËÁøÇÕ´Ï´Ù. ±ÔÁ¦ÀÇ ÁøÀü°ú ǰÁú °ü¸®ÀÇ Á߽à Áõ°¡°¡ ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀ» ´õ¿í °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÌ ¹ÙÀÌ¿À ÀǾàǰ Á¦Á¶¿¡ ¾ö°ÝÇÑ ÁöħÀ» ºÎ°úÇÏ´Â µ¿¾È ÷°¡Á¦ÀÇ Ç°Áú°ú ÄÄÇöóÀ̾𽺿¡ ´ëÇÑ ÁÖ¸ñÀÌ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÀÌ·Î ÀÎÇØ ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀ» ÃæÁ·Çϰí Á¦Ç°ÀÇ ¾ÈÀü¼º°ú È¿´ÉÀ» º¸ÀåÇϴ ÷°¡Á¦ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº R&D ºñ¿ë°ú ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀº ½ÃÀå ¼ºÀåÀ» ¾ïÁ¦ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ ¼³¹® Á¶»ç º¸°í¼­´Â Porter's Five Force ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼® ¹× ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØÀÇ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ Á¶»ç¿¡ ´ëÇÑ Àü¹ÝÀûÀÎ Á¢±Ù¹ýÀ» ¼³¸íÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇϰí ÇâÈÄ ±âȸ¸¦ Áö¿øÇÕ´Ï´Ù.

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑÀÌ º¸°í¼­´Â ¸ðµç ÁÖ¿ä Áö¿ª¿¡¼­ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä, ÃßÁ¤ ¹× ¿¹Ãø¿¡ ÁßÁ¡À» µÓ´Ï´Ù.

¸ÂÃ㠿䱸»çÇ×ÀÌ ÀÖ´Â °æ¿ì ´ç»ç¿¡ ¹®ÀÇÇϼ¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦-¾÷°è ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ¼¼°è ½ÃÀå ºÐ¼® : Á¦Ç°º°

Á¦6Àå ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦7Àå ¹ÙÀÌ¿À ÀǾàǰ ÷°¡Á¦ ±â¾÷°æÀï ±¸µµ

Á¦8Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Biopharmaceutical Excipients Market is presumed to reach the market size of nearly USD 5.32 Billion by 2032 from USD 3.12 Billion in 2023 with a CAGR of 6.12% under the study period 2024-2032.

Biopharmaceutical excipients are inert substances that formulate biopharmaceutical products, such as vaccines, monoclonal antibodies, and gene therapies. They serve various functions, including stabilizing active ingredients, enhancing solubility, and improving drug delivery. These excipients can include substances like stabilizers, preservatives, and solubilizers, and are crucial in ensuring the efficacy, safety, and quality of biopharmaceuticals. Unlike excipients used in traditional pharmaceuticals, they must meet stringent regulatory requirements and compatibility standards to ensure they do not interfere with the biological activity of the active pharmaceutical ingredients (APIs).

Market Dynamics

The increasing demand for biologics and advanced therapeutics drives the biopharmaceutical excipients market. As the biopharmaceutical sector expands, there is a growing need for specialized excipients to enhance biologic drugs' stability, delivery, and efficacy. Excipients play an integral role in formulating complex biologics, such as monoclonal antibodies & gene therapies, which require tailored excipient solutions to maintain product quality and performance. Technological advancements in excipient development are creating significant opportunities within the market. Innovations in excipient technologies, such as novel stabilizers and advanced delivery systems, are improving the formulation and manufacturing of biopharmaceutical products. These advancements enable the development of more effective and safer therapeutics, driving demand for cutting-edge excipients.

The increasing focus on personalized medicine also contributes to biopharmaceutical excipients market growth. Personalized therapeutics often require specialized excipients to address unique formulation challenges and optimize drug delivery. This trend is driving the development of customized excipient solutions to support the growing field of personalized medicine. Regulatory advancements and a growing emphasis on quality control further drive the biopharmaceutical excipients market. As regulatory agencies impose stricter guidelines for biopharmaceutical manufacturing, there is a heightened focus on excipient quality and compliance. This has led to increased investment in the development of excipients that meet rigorous regulatory standards and ensure product safety and efficacy. However, high research and development costs and stringent regulatory requirements may restrain market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Biopharmaceutical Excipients. The growth and trends of Biopharmaceutical Excipients industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Biopharmaceutical Excipients market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Biopharmaceutical Excipients market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Biopharmaceutical Excipients market include Merck KGaA, Colorcon, BASF SE, Associated British Foods Plc, Signet Excipients Pvt. Ltd (IMCD), Sigachi Industries Limited, Spectrum Chemical Manufacturing Corp., Roquette FreRes, IMCD, Clariant, DFE Pharma, J. Rettenmaier & SoHne GmbH + Co KG, Evonik Industries AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. BIOPHARMACEUTICAL EXCIPIENTS - INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY PRODUCT

6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS BY GEOGRAPHY

7. COMPETITIVE LANDSCAPE OF THE BIOPHARMACEUTICAL EXCIPIENTS COMPANIES

8. COMPANY PROFILES OF BIOPHARMACEUTICAL EXCIPIENTS INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â